Evaluation of the Added Value of Sophrology on the Intensity of Craving During Smoking Withdrawal

NCT ID: NCT04700306

Last Updated: 2025-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-23

Study Completion Date

2024-09-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the added value of Sophrology on the intensity of craving during cigarette withdrawal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pilot study to evaluate the impact of sophrology on the intensity of craving and on certain determinants of cigarette consumption: number of cigarettes, anxiety, degree of dependence, motivation, confidence, fatigue, irritability, quality of sleep.

This pilot study could serve as a basis for the development of research on a larger cohort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Craving Cigarette Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sophrology

the patient must make 8 visits with interviews and questionnaires, including 7 visits with a session of sophrology

Group Type EXPERIMENTAL

Sophrology

Intervention Type BEHAVIORAL

Patient must make 8 visits with interviews and questionnaires, including 7 visits with a session of sophrology.

Control

the patient must make 7 visits with interviews and questionnaires

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sophrology

Patient must make 8 visits with interviews and questionnaires, including 7 visits with a session of sophrology.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First outpatient consultation in tobacco addiction department
* Consumption greater than or equal to 35 cigarettes per week
* Minimum age: 18 years old / Maximum age: 75 years old
* Absence of co-addiction of alcohol, other products and behavioural addictions (except if withdrawal for more than 1 year)
* Commitment by the patient not to practice hypnosis or mindfulness while participating in the study
* Mastering reading and writing skills
* Acceptance to participate in the protocol
* Affiliated to a social security system

Exclusion Criteria

* Patient-reported psychosis
* Pregnant women
* Participation in other intervention research
* Patient under guardianship or curatorship
* Refusal to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Intercommunal Creteil

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sylvie Ané

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Intercommunal Créteil

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHI Créteil Equipe de liaison et de soins en addictologie (ELSA)

Créteil, , France

Site Status

CHU Henri Mondor Service d'addictologie

Créteil, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SOPHCIG

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation in Hospitalized Smokers
NCT01289275 COMPLETED PHASE4